Salud financiera de hoja de balance de Globus Medical
Salud financiera controles de criterios 5/6
Globus Medical tiene unos fondos propios totales de $4.2B y una deuda total de $409.7M, lo que sitúa su ratio deuda/fondos propios en 9.8%. Sus activos y pasivos totales son $5.4B y $1.2B respectivamente. Globus Medical El EBIT de la empresa es de $256.8M, por lo que su ratio de cobertura de intereses es de -9.2. Su tesorería e inversiones a corto plazo ascienden a $468.9M.
Información clave
10.4%
Ratio deuda-patrimonio
US$417.40m
Deuda
| Ratio de cobertura de intereses | -13.6x |
| Efectivo | US$517.79m |
| Patrimonio | US$4.00b |
| Total pasivo | US$1.09b |
| Activos totales | US$5.09b |
Actualizaciones recientes sobre salud financiera
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly
Mar 20
Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?
Nov 14Recent updates
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued
Apr 08Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly
Mar 20Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock
Feb 27Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?
Feb 09Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings
Jan 17Globus Medical: Merger Overhang Lingering
Nov 27Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?
Nov 14Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?
Oct 27Globus Medical: Almost Having My Back
Sep 13Globus Medical: Slightly Too Pricey Right Now
Aug 07Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy
Jul 18Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?
Jul 11Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching
Jun 18Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around
Apr 09What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?
Mar 22Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?
Feb 24Globus Medical Q4 2022 Earnings Preview
Feb 20Globus Medical: An Impressive Long-Term Revenue Growth Play
Jan 08Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
Dec 22Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends
Dec 01Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line
Nov 08A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)
Oct 15Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact
Sep 02Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around
Sep 02Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?
Aug 11Globus Medical: Low Rates Sensitivity, Seeking 26% Return Objective
Jun 05Globus Medical (NYSE:GMED) May Have Issues Allocating Its Capital
May 24Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?
May 06An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 22% Undervalued
Mar 14Globus Medical Continues To Flex Its Innovation Muscles To Drive Share Growth
Mar 01Globus Medical's (NYSE:GMED) Performance Is Even Better Than Its Earnings Suggest
Feb 24Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture
Feb 08Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?
Jan 21Are Globus Medical, Inc. (NYSE:GMED) Investors Paying Above The Intrinsic Value?
Nov 28Returns On Capital At Globus Medical (NYSE:GMED) Paint A Concerning Picture
Nov 10At US$76.32, Is Globus Medical, Inc. (NYSE:GMED) Worth Looking At Closely?
Oct 19Globus Medical Continuing To Harness Innovation To Drive Impressive Growth
Aug 24Análisis de la situación financiera
Pasivos a corto plazo: GMEDLos activos a corto plazo ($1.9B) de la empresa superan a sus pasivos a corto plazo ($428.7M).
Pasivo a largo plazo: GMEDLos activos a corto plazo ($1.9B) superan a sus pasivos a largo plazo ($739.9M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: GMED tiene más efectivo que su deuda total.
Reducción de la deuda: GMEDha pasado de 0% a 9.8% en los últimos 5 años.
Cobertura de la deuda: GMEDLa deuda de la empresa está bien cubierta por el flujo de caja operativo (49.5%).
Cobertura de intereses: GMED gana más intereses de los que paga, por lo que la cobertura del pago de intereses no es preocupante.